Process of informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue.

Abstract

The invention relates to a method for informing a therapeutic liquid prior to its administration and / or the transport of a harvested organ or the culturing of organic tissue for reimplantation. It enables re-information and reconnection by means of a liquid or fluid (carrier) that has been encoded by specific scalar frequencies or electromagnetic frequencies.

Description

Title of the invention: Method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue.

[0001] The invention relates to a method for informing a therapeutic liquid prior to its administration and / or the transport of a harvested organ or the culturing of organic tissue for reimplantation. It enables re-information and reconnection by means of a liquid or fluid (support) that has been encoded by specific scalar frequencies or electromagnetic frequencies.

[0002] The invention is an extension of patent FR2412164, the title of which is: Process and formula for the manufacture of an infoceutical.

[0003] There are therapeutic methods available today that cause numerous adverse effects that endanger the patient's life. For example: transfusion of whole blood or a portion thereof.

[0004] Blood transfusion can cause anaphylaxis, a severe allergic reaction that can sometimes be life-threatening. If an allergic reaction occurs, the transfusion is stopped and allergy medications, including antihistamines and steroids, are administered. Acute hemolytic transfusion reaction (AHT) is a rare complication and the most frequent cause of transfusion-related death. AHT usually results from antibodies in the recipient's plasma directed against antigens on the donor's red blood cells. Acute pulmonary edema due to transfusion overload (TACO), also known as transfusion-associated circulatory overload, is a medical emergency and remains the most frequent fatal complication of transfusion. Rejection phenomena are numerous.Furthermore, the administered blood comes from a donor whose characteristics are not identical because each individual possesses their own quantum and subatomic DNA. Moreover, the blood stored for a given recipient does not receive, prior to transfusion, frequency re-information incorporating the necessary corrections to eliminate rejection phenomena and side effects, and to provide the brain, heart, and relevant organs (for example, the cell membrane) with the information to produce the components through a rebalancing of information that is as efficient and favorable as possible for the patient.

[0005] The same applies to the reimplantation or transplantation of an organ.

[0006] Each organ is carefully preserved using special solutions and wrapped in ice before being transported to the transplant center. Processes Specific procedures are in place to ensure that each organ is packaged and labeled correctly. For example, lungs are the most difficult organ to transplant because they are highly susceptible to infection at the end of the donor's life. They can be damaged during removal or collapse after being placed on a ventilator. Despite meticulous precautions and a successful operation, the risk of rejection is always present. Therefore, transplant recipients must, in most cases, take anti-rejection medications, which have destructive long-term effects.According to the invention, organ-specific frequency re-information is also possible through special preservation solutions. This information is supplemented during recipient preparation by taking a blood sample, performing frequency analysis, and communicating the results to the transport services, if possible, for information about the organ or the organ awaiting transplantation. If this is not possible, the information will be integrated into a solution via infusion during and after the operation.

[0007] The body field reacts to three major magnetic fields (Big fields). In terms of health, the physical body, the body field, must be aligned with the Earth's fields for the treatment to work.

[0008] The brain, for its part, does not differentiate between what it perceives as reality and what is imagined. It will therefore use the same neural circuits. (NASA discovery used in the cellular reconnection and re-information protocol). Thus, the invention enables this cellular reconnection and re-information through the processes.

[0009] The control center of the physical body is located in the brain; it is a transcoder, transforming vibrational information into electrical current. This is how the spirit is embodied in matter. This additional information helps to facilitate understanding of the process according to the invention.

[0010] We have already touched on the possible solutions, which will be explained in more detail for a better understanding of the positive effects according to the present invention and its variants.

[0011] The disadvantages reported above are given as examples, the list of which is not exhaustive.

[0012] The invention aims to remedy to some extent the aforementioned disadvantages and to provide innovative advantages.

[0013] The attached drawing will provide a better understanding of the invention by way of example.

[0014] Fig. 1 schematically represents the process according to the invention.

[0015] A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue (1) characterized firstly by taking a sample of whole blood from the individual in question (2) in order to carry out a thorough blood analysis by the biomedical techniques of current laboratories which may include the determination of the pH (potential of hydrogen) then in a second stage with the blood sample an external vegetative test or similarity index will be carried out with a quantum bioresonance device (3).

[0016] The external test is performed with a bioresonance device that has a resonance chamber (4) into which the blood sample is placed and the test is started. The aim is to compare the frequency similarity between the blood sample from the human or animal patient placed in the resonance chamber and, based on the measurements, to determine the necessary frequency corrections that would be favorable according to a standard in a database contained in the bioresonance device. Thus, the corrected blood is transformed into a personalized frequency code (5).

[0017] This first examination makes it possible to compare the data of the two tests in order to promote a corrected whole blood and thus to make the necessary corrections by re-information when introducing it into the body by means of a specific solution encoded by perfusion or injection.

[0018] The two examinations thus performed will allow for a precise determination of the exact composition and proportions of the patient's blood, the organic and inorganic agents affecting blood quality, pathogens, and acquired (genetic) abnormalities. Indeed, the various examinations using conventional and / or artificial intelligence-assisted technologies will provide data essential to the purpose of the therapeutic procedure. However, the assessment would be incomplete or truncated without the assistance of a quantum examination using a bioresonance device that extends DNA analysis to the subatomic level.

[0019] It is specified that the blood profile determination is carried out using whole blood. However, according to a variant, the same procedure can be carried out on one of the blood components.

[0020] Once the assessment has been carried out, the frequency bioresonance device will be used to generate a specific, specialized and personalized corrective frequency code from the patient assessment data and the internal databases contained in the bioresonance device and that the databases are based on the frequencies of the Rifing including in particular the frequencies which include the frequencies of Nogier, Bahr, Reininger, Jade Machine Colors and / or the homeopathic frequencies and / or the frequencies of Bach Flowers and / or the frequencies of plants and / or the frequencies of essential oils and / or the frequencies of the Planets and / or the frequencies of the meridians and / or the frequencies of the Chakras and / or the Musical and Solfège frequencies (5).

[0021] It is perfectly understandable that, within the framework of creating a bioresonance complex, different types of frequencies can be mixed together and associated with the patient's frequency. The frequency is individualized and personalized based on their blood test results.

[0022] According to a variant of the process, allopathic drugs can be used which are transformed into frequencies from the resonance chamber which is an integral part of the bioresonance device and the result in frequency code can be part of the final complex introduced by encoding in the transport solute.

[0023] Once the creation of the frequency complex is complete, it is stored in the bioresonance machine or a transmitter device for encoding frequencies, or in a database that includes the patient. Thus, the frequency complex remains available to the patient at all times, and also allows for necessary adjustments to modify its composition in relation to the improvement and progression of the pathology.

[0024] The frequency complex thus created is encoded in a solute or sterile liquid such as Ringer's Lactate solution or another liquid (6) which can be administered by infusion, injection, or orally. The liquid or solute, depending on the preferred preparation method, is purified and energized. It is then aseptically incorporated into an airtight vial, a flexible bag, or an ampoule (7), which is subsequently encoded by the device from a specific bioresonance chamber connected to the bioresonance emitter (e.g., Spooky 2 or NLS Biospect devices (registered trademarks)) or, when the emitter is directly connected to a computer (e.g., Glowing IC Pad 3 from Infopathy). The principle of frequency encoding uses electromagnetic or magnetic waves or scalar waves.

[0025] The finalized and encoded vial or flexible pouch can receive additional information at any time as long as the product has not been administered to the patient. However, the process also allows the encoding to remain constant during storage until its final use by adding a holographic label, a label with magnetic ink markings, a magnetic stripe, an RFID tag, or an electronic chip to at least part of its surface. To achieve this, the various additional encoding methods for the holographic label, the label with magnetic ink markings, the magnetic stripe, the RFID tag, or the electronic chip are encoded separately using bio-information, that is, before being permanently affixed to the pouch or vial.

[0026] According to another variant, the liquid or solute incorporating the encoded bio-information will benefit, in addition to encoding by frequency or scalar waves, from encoding by light therapy, which is a means of treatment using radiation. non-ionizing electromagnetic, i.e. light most often and / or chromotherapy and / or music therapy.

[0027] A variant of the method consists of using the system called Cell Server during a scheduled or emergency surgical procedure.

[0028] Autologous blood recovery system: Principle: This system allows for the collection of the patient's blood during surgery for reinjection during or after surgery. It is used during surgery with a risk of bleeding. The blood is collected in a reservoir and mixed with heparinized serum. It then passes through a centrifuge to separate the red blood cells, which will be reinjected, from the cellular debris / liquids / plasma, which will be discarded. There are two types of cell savers: one with a washing system and one without.

[0029] Thus the serum bag is encoded according to the process of the invention to transmit the corrective bio-information to the patient's blood upon reintroduction into the body.

[0030] One variant of the application of the method according to the invention consists of informing the organ taken from the donor with additional information about the recipient's characteristics in order to avoid or mitigate rejection phenomena, or at least to minimize said phenomena. Currently, this is done by immersing the taken organ in a preservation liquid with artificial or synthetic ice. The invention of the method also appears advantageous by encoding the liquid or directly the organ with the characteristics of the frequency-based blood test, combined with an encoding forming a complex, for example, a drug transformed by the bioresonance device into a frequency and combined with the frequency of the blood test.

[0031] Another preferred application of the invention lies in the preparation of graft tissues or tissues to be cultured. Indeed, the culture of organic tissues is carried out in dishes containing a nutrient liquid or gel, allowing the tissue or graft to develop under optimal conditions. Thus, the process will use the liquid or gel to impart bio-information to the tissue, which may contain frequencies, to promote rapid and safe tissue growth. This same method will also deliver information to the recipient to prevent rejection. For this variant, the invention uses the same principle as those described above.

[0032] Furthermore, in order for the product to retain its full effectiveness according to all the products and formulas mentioned above and to prevent the encoding from disappearing, the final product benefits from packaging made of fabric or cardboard or biodegradable and / or compostable plastic shielded with Faradey blocking external magnetic waves.

[0033] This written description uses examples to disclose embodiments of the invention, and also to enable any person skilled in the art to carry out embodiments of the invention, including the manufacture and use of any device or system and the performance of any incorporated process. Scope The patentable nature of the invention is defined by the claims and may include other examples that are apparent to a person skilled in the art. These other examples are intended to fall within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with non-substantial differences from the literal language of the claims.

[0034] Of course, the present invention is not limited to the embodiments or fields of activity previously described.

Claims

Demands

1. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue (1) characterized firstly by taking a whole blood sample from the individual in question (2) in order to carry out a thorough blood analysis by current laboratory biomedical techniques which may include the determination of pH (potential of hydrogen) and then in a second step with the blood sample an external vegetative test or similarity index will be carried out with a quantum bioresonance device (3),which has a resonance chamber (4) in which the blood sample will be placed and the process started in order to determine the necessary frequency corrections according to a standard in a database contained in the bioresonance device, then the corrected blood is transformed into a personalized frequency code (5) which forms a frequency complex stored in the bioresonance machine or a transmitter device to encode the frequencies or in a database and encoded in a solute or sterile liquid such as Ringer's Lactate solution or another liquid (6) integrated sterilely into an airtight vial or a flexible bag or an ampoule (7),

2. Method of informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to claim 1 characterized in that the bioresonance complex can be mixed with the different types of frequencies together and associated with the patient's frequency and the frequency is individualized and personalized from his blood test.

3. Method of informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to claim 1 characterized in that the terminal complex of the method may use allopathic drugs which are transformed into frequencies from the resonance chamber forming an integral part of the bioresonance device and that the result in frequency code may be part of the final complex introduced by encoding into the transport solute.

4. Method of informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to claims 1-2-3 characterized in that the creation of the frequency complex is carried out, it is stored in the bioresonance machine or a transmitting device to encode the frequencies or in a database integrating the patient.

5. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to the preceding claims, characterized in that the frequency complex thus created is encoded in a solute or sterile liquid such as Ringer's Lactate solution or another liquid (6) which can be administered by infusion or injection or orally, the purified and energized liquid or solute of which the liquid is then sterilely integrated into a hermetically sealed vial or flexible bag or ampoule (7) which is then encoded by the device from a specific bioresonance chamber connected to the bioresonance transmitter or by a transmitter is directly connected to a computer whose frequency encoding principle uses electromagnetic or magnetic waves or scalar waves.

6. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to the preceding claims, characterized in that the finalized and encoded bottle or flexible pouch can at any time receive additional re-information as long as the product is not administered to the patient, and that the method also allows, during its storage, for it to be constantly under the influence of the encoding until its final use, thanks to the addition on at least part of the surface of a holographic label or a label having inscriptions with magnetic ink or a magnetic stripe or an RFID or an electronic chip using the various complementary encoding means,a holographic label or a label bearing inscriptions with magnetic ink or a magnetic stripe or an RFID or an electronic chip are encoded by the bio-information separately, that is to say before being permanently affixed to said bag or bottle.

7. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to claims 1 and 6, characterized in that the liquid or solute incorporating the encoded bioinformation will benefit, in addition to encoding by frequency or scalar waves, from encoding by light therapy, which is a means of treatment using non-ionizing electromagnetic radiation, i.e. light most often, and / or chromotherapy and / or music therapy.

8. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue is characterized in that the method consists of informing the organ taken from the donor of re-information on the characteristics of the recipient by immersing the organ taken in a preservation liquid with artificial or synthetic ice or by directly encoding the organ with the characteristics of the frequency blood profile combined with a complex encoding.

9. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue is characterized in that the method consists of preparing graft tissues or tissues cultured in dishes containing a nutrient liquid or gel encoded by bio-information that may contain frequencies.

10. A method for informing or re-informing a liquid for therapeutic purposes and / or for the transport or reimplantation of a human or animal organ or tissue according to the preceding claims, characterized in that the product retains all its effectiveness according to all the products and formulas mentioned above and that the encoding does not disappear, the final product benefits from packaging in fabric or cardboard or biodegradable and / or compostable plastic shielded with Faradey blocking external magnetic waves.

Images